Lake is an expert in gene therapy analytics and applying biophysical/mass spectrometric methods to protein science.

With more than 28 peer reviewed publications, BLA/MAA submissions and FDA/EMA responses, Lake frequently speaks at leading scientific conferences. 

“My science is the business. The business is not science.”

Lake is a LinkedIn denizen. Check him out

With over 19 years of experience at the intersection of legal expertise and strategic business development, Sarah is a seasoned professional dedicated to driving organizational success and mitigating risk in complex environments. As the Owner, Chief Strategy Officer, and General Counsel at BioAnalysis, LLC, she plays a pivotal role in shaping the company’s vision and executing strategic initiatives.

During her tenure at Fifth Third Bancorp and Nationwide Mutual Insurance Company, leading financial services companies, she held various leadership roles, including Vice President and Associate General Counsel. In her roles, she spearheaded board governance, managed corporate insurance programs, and provided strategic counsel on compliance and regulatory matters. She also led multifaceted projects, including mergers and acquisitions, asset sales, new product launches, and process improvements, demonstrating her ability to drive impactful change across organizations.

In addition to her professional endeavors, she is deeply committed to community involvement and has volunteered with organizations such as Pro-Bono Partnership of Ohio, Artswave, and Sayler Park Sustains. She is also an active member of industry associations, including serving on the board of Kensington Corridor Trust.

Driven by a passion for excellence and a dedication to making a positive impact, she continues to leverage her expertise to drive innovation, foster growth, and uphold the highest standards of integrity and professionalism in all her endeavors.

As CIO, Charles is focused on new revenue opportunities and business development. He also facilitates growth of new scientific, economic and community efforts.

Dr. Buck graduated from the College of Idaho and received his PhD in molecular neurobiology from the Cornell University Graduate School of Medical Sciences in New York City. In addition to running his own academic research group, he has managed large scale research consortia in both the public and private sectors. His experience includes technology and startup development, molecular biology, proteomics, biofuels, precision medicine, and higher education leadership.

Outside of work, Charles enjoys wandering the streets and pubs of Philadelphia.

Michael is an analytical chemist who has spent over 20 years in a variety of increasing leadership roles at pharmaceutical CROs (SSCI, Aptuit, and Triclinic Labs).

As the Director of Analytics & Research at BioAnalysis, he is responsible for the operation of the laboratory, overseeing the scientific staff, and managing client projects. He is committed to sharing his extensive knowledge of cGMP, experimental design, and business development to help position BioAnalysis as a global leader in the biotech industry.

Michael received his bachelor’s degree from Purdue University.

As Director of Mass Spectrometry, Paige is focused on managing a team of LCMS scientists to develop and implement product-specific mass spectrometry assays to support biotherapeutic drug development.

Paige is an experienced mass spectrometry expert with a strong background in academic, industry and clinical method development. Paige holds a graduate degree in Cancer Biology from Purdue University and has a proven track record in launching new mass spectrometry assays and leading scientific teams to success.

Outside of work, Paige enjoys playing in her small urban garden and visiting Philadelphia’s many art museums.

Angela Mohs, PhD, Director of Research and Analytics at BioAnalysis, is an experienced scientist with 18 years of drug development experience in the pharmaceutical and biotechnology industry with various scientific and management roles of increasing responsibility at Merck Research Laboratories, Ferring Pharmaceuticals, Pfizer Vaccines, PTC Therapeutics as well as smaller biotechnology companies.

Her experience includes formulation development of biologics, analytical development of multiple biologics including antibodies, pegylated proteins, mRNA/LNP vaccines technology and gene therapy products. Angela has worked in early biophysical as well as analytical method development as well as in early and late-stage qualification/validation. She has experience establishing laboratories, managing technical transfers and supporting regulatory filings.

Angela was hired in June 2023 to establish the GMP compliant HPLC laboratory at BioAnalysis to service the pharmaceutical and biotechnology industry.

Angela earned a master’s degree in physics from the Technical University of Dortmund, Germany and a PhD in Biophysics from Humboldt University at Berlin, Germany. She spends her downtime hiking, bicycling or just enjoying being outside.

Mercedes graduated from Purdue University in West Lafayette, Indiana, with a BS in Biochemistry. With over nine years of experience in analytical chemistry, she serves as the Director of Quality Assurance, leading the QA department while advising management on cGMP regulations.

When she’s not working, Mercedes enjoys spending time with her adorable pup, Tootsie

As Director of Business Development, Olivia is working to establish and solidify client relationships, identify symbiotic partnerships, and stay tuned into the ever-changing world of bioanalytical services. She plans on attending scientific meetings and other industry events to represent BioAnalysis, so keep an eye out for her in exhibit halls and sessions (or maybe happy hour?).

Olivia earned her PhD in Molecular Genetics and Biochemistry from the University of Cincinnati and kicked off her career at a biotech startup making recombinant proteins. It wasn’t long before she made the leap from the lab bench to the business side of things. Since then, she has been honing her skills to efficiently, effectively, and strategically increase the value of technical products and services in biological spaces. From clinical trial endpoints to bioanalytical services, Olivia is a problem solver who loves connecting the dots and making things happen. Her deep understanding of both the scientific and business aspects of biotherapeutics development makes her uniquely positioned to help clients navigate their analytical needs throughout the product lifecycle.

Olivia is all about creating community and fun. She juggles life as a mom, dances-it-out at Jazzercise, leads her local swim club as Board President, and babysits her vegetable garden all summer long.